Deals this week: Neuros Medical, Evolent Health, Osprey Medical


Neuros Medical Inc has secured $20m in a series AA Financing round led by US Venture Partners.

The US-based company plans to use the funds to progress its IDE clinical study.

Evolent Health Inc has announced a public offering of seven million class A common stock shares priced at $24.1 each to raise $175m.

"Osprey plans to use the stocks to invest in research and development (R&D) and for marketing of its products."

Located in the US, Evolent plans to use funds to purchase class A common shares.

US-based company Osprey Medical Inc has announced the private placement of 27 million common stock shares priced at A$0.4 ($0.32) each to raise A$22.18m ($17.61m).

Osprey plans to use the stocks to invest in research and development (R&D) and for marketing of its products.